MAK CAPITAL ONE LLC 13F: Quarter-over-Quarter Portfolio Changes
MAK CAPITAL ONE LLC reported a disclosed portfolio value of approximately $713.8 million in its latest SEC Form 13F-HR filing for Q2 2026, up 18.1% quarter on quarter. Over the quarter, the fund initiated 1 new position, bought more shares in 6 holdings, trimmed 3 holdings, and exited 5 positions.
MAK CAPITAL ONE LLC's top buy was Uniqure NV (QURE) . The fund bought 179.2% more shares, lifting the position's portfolio weight by 6.8 percentage points. Its top sell was Champion Homes INC (SKY) . The fund sold 50.7% of its previously reported shares, reducing the position's portfolio weight by 8.0 percentage points.
New PositionsQ2 2026
Securities disclosed for the first time in Q2 2026 that were not present in the prior 13F-HR filing.
| Company | Ticker | Initial Portfolio Weight | History |
|---|---|---|---|
| CARIS LIFE SCIENCES INC | CAI | 4.8% | History → |
Top BuysQ2 2026
The fund's top buys among existing positions in Q2 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.
| Company | Ticker | Portfolio Weight Change | More Shares | History |
|---|---|---|---|---|
| UNIQURE NV | QURE | +6.8% | +179.2% | History → |
| CLEARPOINT NEURO INC | CLPT | +3.1% | +24.9% | History → |
| ANNEXON INC | ANNX | +0.4% | +24.1% | History → |
| PERMA-FIX ENVIRONMENTAL SVCS | PESI | +0.4% | +12.4% | Holders → |
| STANDARD BIOTOOLS INC | LAB | +-0.7% | +10.1% | Holders → |
| GRUPO FINANCIERO GALICIA S.A | GGAL | +-0.6% | +4.0% | History → |
Top SellsQ2 2026
The fund's top sells among positions it retained in Q2 2026. Ranked by portfolio-weight impact. Full exits are listed separately.
| Company | Ticker | Portfolio Weight Change | Shares Sold | History |
|---|---|---|---|---|
| CHAMPION HOMES INC | SKY | -8.0% | 50.7% | History → |
| CRYOPORT INC | CYRX | 0.9% | 10.3% | Holders → |
| COMSTOCK INC | LODE | 0.1% | 10.0% | Holders → |
Full ExitsQ2 2026
Positions present in the prior 13F-HR filing that no longer appear in Q2 2026.
| Company | Ticker | Last-Reported Portfolio Weight |
|---|---|---|
| COURSERA INC | COUR | 5.4% |
| UDEMY INC | UDMY | 2.8% |
| PROTALIX BIOTHERAPEUTICS INC | PLX | 1.3% |
| FIVERR INTL LTD | FVRR | 0.1% |
| SANGAMO THERAPEUTICS INC | SGMO | 0.0% |
Net Portfolio Value ChangeQ2 2026
- $0.6BPrior quarter
- $0.7BCurrent quarter
- +$0.1BNet delta
- +18.1%% change
Methodology & FAQ
How MAK CAPITAL ONE LLC Quarterly Changes Are Computed
All deltas are sourced from sequential SEC Form 13F-HR filings for MAK CAPITAL ONE LLC: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description, including how confidential treatment filings are handled, is documented in the Methodology.
What stocks did MAK CAPITAL ONE LLC buy in Q2 2026?
In Q2 2026, MAK CAPITAL ONE LLC initiated 1 new position (CARIS LIFE SCIENCES INC (CAI)); bought more shares of UNIQURE NV (QURE), CLEARPOINT NEURO INC (CLPT), ANNEXON INC (ANNX), PERMA-FIX ENVIRONMENTAL SVCS (PESI), STANDARD BIOTOOLS INC (LAB) (the largest 5 of 6 adds).
What stocks did MAK CAPITAL ONE LLC sell in Q2 2026?
In Q2 2026, MAK CAPITAL ONE LLC fully sold 5 positions (COURSERA INC (COUR), UDEMY INC (UDMY), PROTALIX BIOTHERAPEUTICS INC (PLX), FIVERR INTL LTD (FVRR), SANGAMO THERAPEUTICS INC (SGMO)); reduced holdings in CHAMPION HOMES INC (SKY), CRYOPORT INC (CYRX), COMSTOCK INC (LODE).
Which positions did MAK CAPITAL ONE LLC initiate in Q2 2026?
MAK CAPITAL ONE LLC established 1 new position in Q2 2026: CARIS LIFE SCIENCES INC (CAI, 4.8%).
Which existing positions saw the largest allocation increases for MAK CAPITAL ONE LLC in Q2 2026?
Of 6 existing positions with share-count increases in Q2 2026, the largest were: UNIQURE NV (QURE, +6.8% weight, +179.2% shares), CLEARPOINT NEURO INC (CLPT, +3.1% weight, +24.9% shares), ANNEXON INC (ANNX, +0.4% weight, +24.1% shares), PERMA-FIX ENVIRONMENTAL SVCS (PESI, +0.4% weight, +12.4% shares), STANDARD BIOTOOLS INC (LAB, +-0.7% weight, +10.1% shares), GRUPO FINANCIERO GALICIA S.A (GGAL, +-0.6% weight, +4.0% shares).
Which positions did MAK CAPITAL ONE LLC fully exit in Q2 2026?
MAK CAPITAL ONE LLC fully exited 5 positions in Q2 2026: COURSERA INC (COUR, last-reported weight 5.4%), UDEMY INC (UDMY, last-reported weight 2.8%), PROTALIX BIOTHERAPEUTICS INC (PLX, last-reported weight 1.3%), FIVERR INTL LTD (FVRR, last-reported weight 0.1%), SANGAMO THERAPEUTICS INC (SGMO, last-reported weight 0.0%).
Which existing positions saw the largest allocation reductions for MAK CAPITAL ONE LLC in Q2 2026?
Of 3 existing positions with share-count reductions in Q2 2026, the largest were: CHAMPION HOMES INC (SKY, -8.0% weight, -50.7% shares), CRYOPORT INC (CYRX, 0.9% weight, -10.3% shares), COMSTOCK INC (LODE, 0.1% weight, -10.0% shares).
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.